Certificate in Psychedelic-Assisted Therapies
The course is based on the CIIS program, adapted for the Australian context, and with input from MAPS, USONA, and others. It teaches therapists the research, therapy setting, risks, and therapeutic models for working with psychedelics.
Provider
Details
Enrollment
Course Overview
The Certificate in Psychedelic-Assisted Therapies (CPAT) by Mind Medicine Australia (MMA) is designed to meet the growing demand for trained therapists to provide regulatory-approved and research-backed psychedelic-assisted therapies for mental ill-health treatment in Australia. The course also prepares clinicians to work in research trials as they expand within the country.
Following world best practices, the CPAT is developed based on protocols from MAPS and the REBUS model by Imperial College London. The course aims to equip therapists with state change and stage change theory and technique, provide a theory of mind perspective, train therapists for future demands, help with the mental health crisis, contribute to changing attitudes and supporting legal changes, establish standards for safe and ethical practice, and bring together medical approaches with good psychotherapy standards and transpersonal aspects.
The CPAT program was developed through collaboration with experienced psychotherapists and incorporated live lectures, webcasts, self-study, and experiential workshops led by a skilled teaching team. The course respects the local context within Australia, making it the first program of its kind in the Southern Hemisphere.
Who is this for?
Medical, Mental Health and Allied Health Professionals in Australia
Prerequisites
The course has 4 assessment requirements:
About the Provider
Mind Medicine Australia is a national nonprofit that has played a defining role in Australia's regulated psychedelic-access environment. Its public work spans rescheduling advocacy, implementation support, clinician training, patient support funding, and ongoing efforts to broaden access pathways. Although it is broader than a pure patient group, it is too important to leave out of Blossom's access map. The organization now reports active involvement in regulatory follow-through, rollout improvements, patient support, and collaboration with End Wise on palliative-care expansion.
View Mind Medicine Australia profileCourse Details
- Price$9,950
- FormatHybrid
- Lifecycle statusDiscontinued
- Skillstherapist training australiaMAPS protocol implementationchange theoryexperiential learningIntegrationFacilitationPsychotherapyKetamine-Assisted TherapyPsilocybin TherapyMDMA-Assisted TherapyMicrodosingEthicsMusic and Set/Settingresearch
- Categories
Related Courses
View all coursesATMA Advanced Psychedelic-Assisted Therapy (PAT) Certification Program
By Atma Journey
This course is made for mental health professionals (in Canada) who want to learn how to work with psychedelics. The course staff includes Mark Haden Anthony Bossis, and many more.
Next cohort: Jul 13, 2026
Add Spravato® to Your Practice with Our 8-Phases Implementation Roadmap
By Ketamine Academy
Spravato FastTrack is an implementation course for clinics that want to add Spravato (esketamine) services. It covers REMS certification, procurement, prior authorization, billing, documentation, and related operational steps.
TheraPsil's Training Program
By TheraPsil
TheraPsil's professional training pathway prepares healthcare professionals and related practitioners for legal, ethical psychedelic-assisted care through didactic learning, live seminars, experiential components, and practicum-oriented training.
Course options
Fundamentals
Standard on-demand access
Full Programme
Standard on-demand access
Fundamentals
Standard on-demand access
Advanced
Standard on-demand access
Full Programme
Standard on-demand access
New Mexico Track
Standard on-demand access